
    
      A randomized, double-blind, vehicle-controlled study to assess the safety, tolerability,
      pharmacokinetics, and pharmacodynamics of intravenously administered PRT064445 after dosing
      to steady state with one of four direct/indirect fXa inhibitors in healthy volunteers
    
  